Home > Boards > US Listed > Biotechs > iBio, Inc. (IBIO)

... it's normally a very lengthy period of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
guay Member Profile
 
Followed By 32
Posts 3,506
Boards Moderated 0
Alias Born 08/04/09
160x600 placeholder
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 10/27/2020 5:01:01 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 10/23/2020 5:21:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2020 4:06:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/16/2020 4:06:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2020 6:10:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2020 6:10:08 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2020 6:09:10 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/16/2020 6:08:32 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/16/2020 6:07:29 AM
Accomplished Financial Executive, Gary Sender, Joins iBio’s Board of Directors GlobeNewswire Inc. - 10/15/2020 4:05:10 PM
iBio Announces Appointment of Dr. Alexandra Kropotova to Board of Directors GlobeNewswire Inc. - 10/15/2020 7:30:10 AM
iBio Announces Appointment of Dr. Linda Armstrong to Board of Directors GlobeNewswire Inc. - 10/14/2020 4:05:10 PM
Annual Report (10-k) Edgar (US Regulatory) - 10/13/2020 5:19:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/13/2020 4:28:18 PM
iBio Announces Financial Results for Fiscal Year Ended June 30, 2020 GlobeNewswire Inc. - 10/13/2020 4:05:10 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 10/13/2020 7:00:49 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2020 4:31:28 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/5/2020 8:32:16 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/5/2020 8:01:44 AM
iBio Regains Compliance with NYSE American Continued Listing Standards GlobeNewswire Inc. - 10/5/2020 7:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/2/2020 7:31:01 AM
iBio Enters into Agreement with Safi Biosolutions to Develop Growth Factors and Cytokines Using the FastPharming® System GlobeNewswire Inc. - 10/2/2020 7:00:10 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 9/28/2020 6:07:20 AM
iBio to Advance COVID-19 LicKM-Subunit Vaccine Candidate, IBIO-201 GlobeNewswire Inc. - 9/9/2020 8:45:10 AM
iBio and Planet Biotechnology Enter into Exclusive Worldwide License Agreement for the Development of a COVID-19 Therapeutic GlobeNewswire Inc. - 8/28/2020 7:15:10 AM
guay   Friday, 08/21/20 05:44:01 AM
Re: None
Post # of 25162 
Quote:
... it's normally a very lengthy period of time to develop a vaccine, and it's critically important, right? Because when it's different than therapeutics, this is a vaccine that you're putting into healthy people. So, of course, we're all hopeful that, all of these vaccines will be successful in human clinical trials. However, there is some benefit, of course, to really focusing naturally on safety, since you're gonna be dosing healthy people, and also get the efficacy as well, and that's why we're taking this extra time to compare the adjuvants and antigen pairings so that we can be more confident when we go into our human clinical trials that the vaccine that we have has the right safety profile and one that can be applicable to our most vulnerable populations, so meaning, especially, the elderly. So, certainly we've got to be able to move fast. And then, once you've got hopefully an optimized, in our case, vaccine candidate to take forward, you then have to be very ready to go ahead and scale up and make sure that the manufacturing and what you're testing now in these early days in the research phase, is gonna be representative of what you're making and putting into people for human clinical trials when you’re at scale ...

from the "Coronavirus Report: The Hill's Steve Clemons interviews Thomas Isett"

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences